In a study of 57 children suffering from acute lymphoblastic leukemia or non-Hodgkin lymphoma (NHL) receiving high-dose cytarabine, PCT levels were analyzed in a randomly selected subgroup of 16 patients [33]. This evidence concerns the gene CALCA and non-Hodgkin lymphoma.